EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Knowledge and Views of Patients With Cardiovascular Disease Toward Pharmacogenomics in The United Arab Emirates

Maram O Abbas iD, Azhar T Rahma iD, Iffat Elbarazi iD, Bassam R Ali iD, George P Patrinos iD, Farah Nagy iD, Alya Osman iD, Reem K Alneyadi iD, Anwar S Alshamsi iD, Mohamed Alraqabani iD, Zeina Al-Mahayri iD, Fatma Al-Maskari iD

Clinical and Translational Science · 2025

DOI: 10.1111/cts.70300 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, 2025. Verfasst von Maram O Abbas und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Health Knowledge, Attitudes, Practice, Pharmacogenetics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pharmacogenomics (PGx) can potentially tailor medication prescriptions to the genetic profiles of individuals, enhancing treatment outcomes and minimizing adverse drug reactions. This study assessed cardiovascular disease (CVD) patients' knowledge and views toward PGx testing in the United Arab Emirates (UAE). A cross‐sectional study was conducted among CVD patients attending multiple clinics using a validated, culturally adapted, and piloted bilingual questionnaire. Participants were invited via phone calls or in‐person contact at clinics. Data analysis was conducted using SPSS V.29, incorporating descriptive statistics and multivariable logistic regression. A total of 425 responses were analyzed; 67.5% were over 50 years old, and 67.5% held a bachelor's degree. Chronic diseases, excluding CVD, affected 65.2%, with 58.1% reporting medication side effects and 36.5% was hospitalized due to these effects. Knowledge varied, with 55.3% demonstrating good knowledge; 75.3% recognized DNA as gene‐based, while 47.5% understood PGx for predicting medication responses. Participants were grouped into three PGx perception clusters: Cluster 1 (33.17%) concerned about risks but valued PGx, Cluster 2 (40.23%) worried about privacy/costs, and Cluster 3 (26.58%) confident in PGx benefits. Safety was the top priority for 60.2% of respondents, 34.8% would not pay for PGx tets, and 35.3% preferred preemptive testing. Regression linked higher PGx knowledge to females, non‐healthcare workers, those with genetic diseases, and those hospitalized for side effects ( p < 0.05). The study highlights a need for educational initiatives in the UAE to improve PGx literacy among CVD patients. The findings suggest that targeted awareness campaigns, policy interventions addressing privacy, and financial support could promote PGx wider adoption.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesHealth Knowledge, Attitudes, PracticePharmacogeneticsHumansUnited Arab EmiratesFemaleMaleMiddle AgedCross-Sectional StudiesAdultSurveys and QuestionnairesAgedPharmacogenomic Testing

Stichwörter der Autor:innen

United Arab Emiratescardiovascular diseasespatient knowledge and attitudespharmacogenomics

Autor:innen und Institutionen

  • Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE.
  • Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE.
  • Zayed Center for Health Sciences, United Arab Emirates University, Al Ain, UAE.
  • Department of Pharmacy, School of Health Sciences, University of Patras, Patras, Greece.
  • Department of Pharmacy Practice, Dubai Pharmacy College, Dubai, UAE.
  • Rashid Hospital, Dubai Health Authority, Dubai, UAE.

ORCID-Profile: Maram O Abbas, Azhar T Rahma, Iffat Elbarazi, Bassam R Ali, George P Patrinos, Farah Nagy, Alya Osman, Reem K Alneyadi, Anwar S Alshamsi, Mohamed Alraqabani, Zeina Al-Mahayri, Fatma Al-Maskari

Zitieren

APA

Abbas, M. O., Rahma, A. T., Elbarazi, I., Ali, B. R., Patrinos, G. P., Nagy, F., Osman, A., Alneyadi, R. K., Alshamsi, A. S., Alraqabani, M., Al-Mahayri, Z., & Al-Maskari, F. (2025). Knowledge and Views of Patients With Cardiovascular Disease Toward Pharmacogenomics in The United Arab Emirates. Clinical and Translational Science. https://doi.org/10.1111/cts.70300

Vancouver

Abbas MO, Rahma AT, Elbarazi I, Ali BR, Patrinos GP, Nagy F, et al. Knowledge and Views of Patients With Cardiovascular Disease Toward Pharmacogenomics in The United Arab Emirates. Clinical and Translational Science. 2025. doi:10.1111/cts.70300

BibTeX
@article{Abbas2025,
  author = {Abbas, Maram O and Rahma, Azhar T and Elbarazi, Iffat and Ali, Bassam R and Patrinos, George P and Nagy, Farah and Osman, Alya and Alneyadi, Reem K and Alshamsi, Anwar S and Alraqabani, Mohamed and Al-Mahayri, Zeina and Al-Maskari, Fatma},
  title = {Knowledge and Views of Patients With Cardiovascular Disease Toward Pharmacogenomics in The United Arab Emirates},
  journal = {Clinical and Translational Science},
  year = {2025},
  doi = {10.1111/cts.70300}
}
Kostenlos starten →